Study Purpose: The study aims to learn if a type of surgery is better than normal care for people with a brain bleed called an intracerebral hemorrhage. This surgery is called minimally invasive because it uses a small opening in the skull to remove the blood. Researchers want to see if this helps patients recover better than the usual medical care.

Eligibility: Participants must be aged 18-70, have a specific type of brain bleed, and be able to start the study treatment within 24 hours of symptoms. Certain medical conditions or treatments disqualify participation.

• Benefits and Risks: This trial could help improve recovery options for brain bleeds, but surgery and medical treatments have risks.
• Study Involvement: Participants will receive either standard care or the new surgery method to compare outcomes.
• Commitment: Participants should be able to attend follow-up appointments and provide informed consent.

The study is called the REACH trial, which stands for Rapid Evacuation and Access of Cerebral Hemorrhage Trial. It's important to understand all aspects and talk to doctors before deciding to join.